Bloomberg Merck & Co.’s cancer treatment Keytruda was almost twice as successful at shrinking lung cancer tumors than a standard chemotherapy regimen, a study of the drug in previously untreated patients found. In the 123-patient study, 55 percent of those on Keytruda plus two chemotherapy drugs saw their tumors get smaller, compared with 29 percent on just the chemotherapy ...
Read More »